Literature DB >> 7541611

De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

A Matolcsy1, A Chadburn, D M Knowles.   

Abstract

Diffuse large B cell lymphomas (DLBLs) represent a heterogeneous collection of aggressive non-Hodgkin's lymphomas that can arise either de novo or as a result of transformation from chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphomas, or lymphomas of mucosa-associated lymphoid tissue. A small percentage of DLBLs express the CD5 antigen. The majority of these cases have evolved from a pre-existing low grade non-Hodgkin's lymphoma (Richter's syndrome). However, we identified and characterized nine CD5-positive DLBLs in which the patients did not have a previous history or concomitant evidence of chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma, or mucosa-associated lymphoid tissue-associated non-Hodgkin's lymphoma, suggesting that they arose de novo. All nine cases expressed CD20 and monotypic immunoglobulin, all eight cases examined expressed CD19, CD22 and CD43, eight of the nine cases expressed HLA-DR, and two of eight cases expressed CD11c. None of the cases expressed CD3, CD10, CD11b, CD21, CD23 or CD30. CD5 expression by these cells was found to be identical to that of CD5-positive B cell chronic lymphocytic leukemia by quantitative polymerase chain reaction analysis of CD5 mRNA. These nine de novo CD5-positive DLBLs exhibited clonal immunoglobulin heavy and light chain gene rearrangements but lacked integration of the Epstein-Barr virus genome and structural alterations of the bcl-1, bcl-2, c-myc, H-ras, K-ras, and N-ras proto-oncogenes and the p53 tumor suppressor gene. However, bcl-6 proto-oncogene rearrangement, which is involved in chromosome band 3q27 aberrations, was found in four cases (44.4%). This is comparable with the frequency of bcl-6 gene rearrangement in CD5-negative DLBL. In contrast, bcl-6 gene rearrangement was absent in six cases of DLBL associated with Richter's syndrome. These findings suggest that de novo CD5-positive DLBLs are genotypically similar to CD5-negative DLBLs and may be pathogenetically distinct from the DLBLs associated with Richter's syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541611      PMCID: PMC1869880     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

Review 1.  Development and function of the early B cell repertoire.

Authors:  J F Kearney; J Bartels; A M Hamilton; A Lehuen; N Solvason; M Vakil
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

Authors:  B H Ye; F Lista; F Lo Coco; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

4.  Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers.

Authors:  D M Knowles; J P Halper; W Azzo; C Y Wang
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

5.  Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin.

Authors:  S V Suggs; R B Wallace; T Hirose; E H Kawashima; K Itakura
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  Variable amplification of immunoglobulin lambda light-chain genes in human populations.

Authors:  R A Taub; G F Hollis; P A Hieter; S Korsmeyer; T A Waldmann; P Leder
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

7.  Histologic progression in non-Hodgkin's lymphoma.

Authors:  S M Hubbard; B A Chabner; V T DeVita; R Simon; C W Berard; R B Jones; A J Garvin; G P Canellos; C K Osborne; R C Young
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

8.  Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes.

Authors:  M M Farrugia; L J Duan; M D Reis; B Y Ngan; N L Berinstein
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

9.  Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.

Authors:  L R Zukerberg; L J Medeiros; J A Ferry; N L Harris
Journal:  Am J Clin Pathol       Date:  1993-10       Impact factor: 2.493

10.  Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.

Authors:  S J Korsmeyer; P A Hieter; J V Ravetch; D G Poplack; T A Waldmann; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  15 in total

1.  Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.

Authors:  Z Szereday; B Csernus; M Nagy; T László; R A Warnke; A Matolcsy
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  CD5+ diffuse large B-cell lymphoma with hemophagocytosis.

Authors:  Jan K Davidson-Moncada; Emily McDuffee; Mark Roschewski
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

Review 3.  Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.

Authors:  Xiaohui Zhang; Manhua Sun; Ling Zhang; Haipeng Shao
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

4.  Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.

Authors:  Hiroyuki Momota; Yoshitaka Narita; Akiko M Maeshima; Yasuji Miyakita; Aya Shinomiya; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  J Neurooncol       Date:  2009-12-13       Impact factor: 4.130

5.  De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.

Authors:  Sun-Young Kong; Eun Hae Cho; Hee Yeon Woo; Qeuhn Park; Young Hyeh Ko; Sun-Hee Kim
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

Review 6.  Diagnosis and treatment of CD20 negative B cell lymphomas.

Authors:  Tasleem Katchi; Delong Liu
Journal:  Biomark Res       Date:  2017-02-07

7.  Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas.

Authors:  M Kume; R Suzuki; Y Yatabe; Y Kagami; I Miura; A B Miura; Y Morishima; S Nakamura; M Seto
Journal:  Jpn J Cancer Res       Date:  1997-11

Review 8.  Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.

Authors:  Carlos A Tirado; Weina Chen; Rolando García; Kelly A Kohlman; Nagesh Rao
Journal:  J Hematol Oncol       Date:  2012-09-11       Impact factor: 17.388

9.  Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience.

Authors:  Mohammad Javad Ashraf; Alireza Makarempour; Ahmad Monabati; Negar Azarpira; Bijan Khademi; Afsoon Hakimzadeh; Elham Abedi; Bita Valibeigi
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

10.  Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.

Authors:  Rieko Kano; Hiroaki Masaie; Akihisa Hino; Hironao Yasuoka; Shigenori Nagata; Jun Ishikawa; Shin-Ichi Nakatsuka
Journal:  Diagn Pathol       Date:  2018-07-24       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.